This ADCC process relies on trogocytosis, initiated by the binding of a tumor-opsonizing antibody to the Fc receptors on the neutrophil and the active CD11b/CD18 integrins [24,25,26,27]. This evidence concerns the gene ITGB2 and neoplasm.